Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 Next >
Bayer announces five-point plan to effectively address potential future Roundup™ claims
From Bayer
Via Business Wire
Long-term Data on Vitrakvi® (larotrectinib) Further Demonstrate Strong Clinical Profile in Patients with TRK Fusion Cancer Regardless of Tumor Type and Age
From Bayer
Via Business Wire
Bayer Announces New Commercial Leaders for Crop Science Division to Accelerate Growth and Drive Business Transformation
From Bayer
Via Business Wire
Bayer Presents Latest Data and New Research to Advance Cancer Care within Oncology Portfolio at 2021 ASCO Annual Meeting
From Bayer
Via Business Wire
Bayer’s Finerenone Meets Primary Endpoint in Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients With Chronic Kidney Disease and Type 2 Diabetes
From Bayer
Via Business Wire
Bayer Pharmaceuticals Taps Two Leaders for New Roles in the U.S.
From Bayer
Via Business Wire
Enhanced Bayer Carbon Program Offers Growers New Opportunities in 2021 and Beyond
From Bayer
Via Business Wire
Investigational Combination of Aliqopa® (copanlisib) and rituximab Significantly Increases Progression-Free Survival in Patients with Relapsed Indolent non-Hodgkin's Lymphoma
From Bayer
Via Business Wire
Bayer to Present New Clinical Data in Indolent non-Hodgkin's Lymphoma and Additional Research on its Oncology Portfolio at AACR Annual Meeting 2021
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.